Mitral stenosis
Also known as: Mitral valve stenosis, Stenosis of the mitral valve, Mitral valve narrowing
Mitral stenosis is characterised by narrowing of the mitral valve orifice, impeding blood flow from the left atrium into the left ventricle. Clinical manifestations include dyspnoea, fatigue, pulmonary congestion, atrial fibrillation, and systemic embolism. Management requires echocardiographic monitoring and specialist cardiological assessment to determine pharmacological or surgical intervention. Traditional Chinese Medicine is limited to supportive symptom management for medically stable patients; these interventions do not address the structural valvular obstruction. There are no direct clinical trials investigating acupuncture or the listed herbal formulas for mitral stenosis. Evidence from a case report on postoperative PVCs [1] and an uncontrolled series on postoperative stroke [4] does not establish efficacy for this condition. Furthermore, the genetic study [2] and research on stroke-related heart failure [3] provide no treatment evidence for mitral stenosis.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Adhere to all scheduled cardiological assessments and echocardiographic monitoring; provide practitioners with a current list of all medications and supplements.
- •Modulate physical activity according to cardiological recommendations; cease activity and seek medical evaluation for new-onset dizziness, chest pain, or disproportionate dyspnoea.
- •Maintain prescribed sodium and fluid restrictions and daily weight monitoring; avoid self-initiating restrictive diets or herbal diuretics.
- •Prioritise meticulous oral hygiene and regular dental reviews; consult the treating cardiac team regarding any valve-related procedural precautions.
Cautions & Contraindications
- •Defer elective acupuncture and herbal initiation during suspected decompensated heart failure, acute stroke or haemodynamic instability. References [3] and [4] provide clinical context only, not formal contraindication guidance.[,]
- •Do not substitute herbs for anticoagulation, rhythm treatment or valve intervention. The single postoperative PVC case [1] does not establish safety or benefit for the formulas listed here, prosthetic-valve patients or active mitral stenosis.[]
- •Do not infer broad procedural safety from the absence of reported adverse events in 51 postoperative stroke patients. Assess anticoagulation, bleeding, wounds, infection and medical stability individually before needling; the case series does not establish safety in these subgroups.[]
When to reassess or seek care again
If medically cleared for adjunctive care, review after 2–4 weeks using fatigue and sleep scores, palpitation frequency, daily activity tolerance and adverse effects. Follow the cardiologist's separate valve-surveillance schedule. Stop adjunctive treatment if symptoms worsen or there is no meaningful benefit; refer promptly for increasing breathlessness, oedema or sustained palpitations, and use emergency pathways for red flags. Pattern changes do not establish changes in valve severity.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Medicine · 2026
- BMC cardiovascular disorders · 2025
- Frontiers in cardiovascular medicine · 2026
- Perioperative medicine (London, England) · 2024
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
